Healthcare Regulation (HIPAA)

The national benefits law firm is expanding its West Coast presence to meet rising demand in the Bay Area's complex regulatory and competitive landscape.

A new partnership embeds programmatic ads into electronic health records, promising hyper-targeted marketing but raising questions about clinical disruption.

CareXM's new conversational AI replaces frustrating phone menus, aiming to ease clinician burnout and improve patient access amid a workforce shortage.

A new partnership aims to move AI from experimental pilots to governed, production-ready agents in finance, healthcare, and energy.

Following key acquisitions, Ntracts promotes six executives, signaling a major push to unify its platform and tackle healthcare's growing complexity.

Yuki's new 14-day free trial runs its full optimization platform on live Snowflake workloads, promising real savings instead of just simulations.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

Groom Law Group adds top talent from DOL, HHS, and IRS, deepening its 'insider's view' on complex benefits and health regulations for clients.

The healthcare virtual assistant market is set to explode, promising radical efficiency but raising critical questions about privacy, bias, and patient trust.

A major acquisition turned sour, a 25% stock crash, and now a class action lawsuit. Inside Perrigo's costly infant formula venture and what it means.

HCIactive's SmartBenefits.ai promises AI-powered clarity for your health plan, but a major data breach reveals the high-stakes risks of this new frontier.

Recent CPSC warnings reveal deadly products on the market. As regulators struggle with e-commerce, can AI become the tool we need to stop them?

AI agents connect to your most critical systems, creating hidden risks. A new class of security tools aims to map and neutralize these invisible threats.

A new alliance aims to streamline at-home diagnostics for pharma, but who is accountable for patient data and safety in this rapidly growing market?